These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A case with glucagonoma syndrome--heterogeneity of glucagon and insulin. Fukushima H; Yamaguchi K; Uzawa H Endocrinol Jpn; 1981 Oct; 28(5):575-82. PubMed ID: 6284494 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure. Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399 [TBL] [Abstract][Full Text] [Related]
6. Multiple hormone secretion by a human pancreatic glucagonoma in culture. White A; Tan K; Gray C; Roberts I; Ratcliffe JG Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720 [TBL] [Abstract][Full Text] [Related]
7. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus. Spinas GA; Bock A; Keller U Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093 [TBL] [Abstract][Full Text] [Related]
8. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor. Wilson DM; Hoffman AR Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570 [TBL] [Abstract][Full Text] [Related]
9. Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor. Kohnert KD; Kändler C; Woltanski KP; Ziegler M Exp Clin Endocrinol; 1985 Feb; 85(1):89-94. PubMed ID: 2985414 [TBL] [Abstract][Full Text] [Related]
10. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans. Creutzfeldt W; Lembcke B; Fölsch UR; Schleser S; Koop I Am J Med; 1987 May; 82(5B):49-54. PubMed ID: 2884879 [TBL] [Abstract][Full Text] [Related]
11. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500. Hendriks T; Jansen JB; van Tongeren JH Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691 [TBL] [Abstract][Full Text] [Related]
12. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism. Hayashi M; Floyd JC; Pek S; Fajans SS J Clin Endocrinol Metab; 1977 Apr; 44(4):681-94. PubMed ID: 14970 [TBL] [Abstract][Full Text] [Related]
13. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome. Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823 [TBL] [Abstract][Full Text] [Related]
14. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome. Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384 [TBL] [Abstract][Full Text] [Related]
15. Effect of somatostatin analogue (SMS 201-995) on molecular species of gastrin in gastrinoma. Campagnolo D; Gower WR; Fabri PJ; Sparks J; Mekhjian HS; O'Dorisio TM; Ellison EC Surgery; 1987 Dec; 102(6):982-7. PubMed ID: 2891204 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment with SMS 201-995 of Cushing's syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin-secreting pancreatic islet cell carcinoma. Lamberts SW; Tilanus HW; Klooswijk AI; Bruining HA; van der Lely AJ; de Jong FH J Clin Endocrinol Metab; 1988 Nov; 67(5):1080-3. PubMed ID: 2846625 [TBL] [Abstract][Full Text] [Related]
17. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones. George SR; Hegele RA; Burrow GN Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554 [TBL] [Abstract][Full Text] [Related]
18. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085 [TBL] [Abstract][Full Text] [Related]
19. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma. Valverde I; Lemon HM; Kessinger A; Unger RH J Clin Endocrinol Metab; 1976 May; 42(5):804-8. PubMed ID: 178682 [TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism. Glaser B; Valtysson G; Fajans SS; Vinik AI; Cho K; Thompson N Metabolism; 1981 Oct; 30(10):1001-10. PubMed ID: 6116152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]